Agrofresh — AgroFresh Solutions, Inc. Third Quarter 2021 Supplemental Earnings Presentation · Slide 2
Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 22022
Alkermes — Nemvaleukin Alfa: A Novel, Engineered Interleukin-2 (IL-2) Variant Immunotherapy · Slide 22022
Alkermes — Proposed Separation of Oncology Business & Third Quarter 2022 Financial Results · Slide 22022